Google DeepMind's AlphaGenome 2 improves predictions of disease-linked genetic variants using 107 million cell profiles, with potential benefits for drug research.
The post AlphaGenome 2: Google’s New AI Gets Better at Decoding Disease-Linked DNA appeared first on TechRepublic.
